Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
Recall Number: D-0984-2017
Firm: Teva Pharmaceuticals USA
Classification: Class III
Status: Terminated
Report Date: 20170726
Initiation Date: 20170629
Termination Date: 20180426
Reason for Recall
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Product Description
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56